Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $124.5900 (0.47%) ($122.5600 - $125.3500) on Sun. Apr. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.62% (three month average) | RSI | 90 | Latest Price | $124.5900(0.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.4% a day on average for past five trading days. | Weekly Trend | LGND advances 6.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting LGND price | LGND will decline at least -1.31% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.31% (StdDev 2.62%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $120.61(3.3%) | 10 Day Moving Average | $117.8(5.76%) | 20 Day Moving Average | $111.15(12.09%) | To recent high | 0% | To recent low | 45.2% | Market Cap | $N/A | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |